ID

22111

Descripción

The present pharmacokinetic study is designed to assess the pharmacokinetics of RSG XR as monotherapy in patients with mild Alzheimer's disease (AD) as such information will not be obtained from the current phase III trials . The study aims to enroll fourteen patients (seven of each APOE genotype). Each patient will receive a single oral dose of 4mg of RSG XR in the morning under fasted conditions and PK samples will be taken up to 36h. GSK Source & Descriptions: https://clinicaltrials.gov/ct2/show/NCT00688207?term=NCT00688207&rank=1

Link

https://clinicaltrials.gov/ct2/show/NCT00688207?term=NCT00688207&rank=1

Palabras clave

Versiones (2)
  1. 8/5/17 8/5/17 -
  2. 20/5/17 20/5/17 -
Subido en

20 de mayo de 2017

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY-NC 3.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

  • El más nuevo
  • Más antiguo
  • Popular
  • El más nuevo
    • El más nuevo
    • Más antiguo
    • Popular

Sin comentarios

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Concomitant Medications Mild Alzheimer's Disease to Assess the of Extended Release Formulation of Rosiglitazone NCT00688207 / GSK-AVA109941

Inglés

Concomitant Medications Mild Alzheimer's Disease to Assess the of Extended Release Formulation of Rosiglitazone NCT00688207 / GSK-AVA109941

1 formularios  
Concomitant Medication
Descripción

Concomitant Medication

Alias
UMLS CUI-1
C2347852
Were any concomitant medications taken by the subject during the study? if YES record each medication on a separate line using Trade Names where possible. If yes, record each medication on a separate line using Trade Names where possible.
Descripción

Concomitant Medication

Tipo de datos

boolean

Alias
UMLS CUI [1]
C2347852
Medication
Descripción

Medication

Alias
UMLS CUI-1
C0013227
Drug name (Trade Name preferred) e.g. Aspirin
Descripción

Drug name

Tipo de datos

text

Alias
UMLS CUI [1]
C0013227
Unit Dose e.g. 200
Descripción

Unit Dose

Tipo de datos

float

Alias
UMLS CUI [1,1]
C0869039
UMLS CUI [1,2]
C0013227
Units* (eg. mg)
Descripción

Units

Tipo de datos

text

Alias
UMLS CUI [1,1]
C1519795
UMLS CUI [1,2]
C0013227
Frequency* (e.g. BID)
Descripción

Frequency

Tipo de datos

text

Alias
UMLS CUI [1,1]
C3476109
UMLS CUI [1,2]
C0013227
Route* (e.g. PO)
Descripción

Route

Tipo de datos

text

Alias
UMLS CUI [1]
C0013153
Reason for Medication (e.g. Headache)
Descripción

Reason for Medication

Tipo de datos

text

Alias
UMLS CUI [1,1]
C0392360
UMLS CUI [1,2]
C0013227
Start Date (e.g. 31 May 03)
Descripción

Start Date

Tipo de datos

date

Alias
UMLS CUI [1,1]
C0013227
UMLS CUI [1,2]
C0808070
Start time (e.g. 14:10)
Descripción

Start time

Tipo de datos

time

Unidades de medida
  • hh:min
Alias
UMLS CUI [1,1]
C0013227
UMLS CUI [1,2]
C1301880
hh:min
Taken Prior to Study? (e.g. N)
Descripción

Taken Prior to Study

Tipo de datos

boolean

Alias
UMLS CUI [1]
C2826667
Stop Date (e.g. 31 May 03)
Descripción

Stop Date

Tipo de datos

date

Alias
UMLS CUI [1,1]
C0013227
UMLS CUI [1,2]
C0806020
Stop Time (e.g. 23:00)
Descripción

Stop Time

Tipo de datos

time

Alias
UMLS CUI [1,1]
C0013227
UMLS CUI [1,2]
C1522314
Ongoing Medication? (e.g. N)
Descripción

Ongoing Medication

Tipo de datos

boolean

Alias
UMLS CUI [1]
C2826666
Volver a la parte superior de la página

Similar models

Concomitant Medications Mild Alzheimer's Disease to Assess the of Extended Release Formulation of Rosiglitazone NCT00688207 / GSK-AVA109941

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
Concomitant Medication
C2347852 (UMLS CUI-1)
Concomitant Medication
Item
Were any concomitant medications taken by the subject during the study? if YES record each medication on a separate line using Trade Names where possible. If yes, record each medication on a separate line using Trade Names where possible.
boolean
C2347852 (UMLS CUI [1])
Item Group
Medication
C0013227 (UMLS CUI-1)
Drug name
Item
Drug name (Trade Name preferred) e.g. Aspirin
text
C0013227 (UMLS CUI [1])
Unit Dose
Item
Unit Dose e.g. 200
float
C0869039 (UMLS CUI [1,1])
C0013227 (UMLS CUI [1,2])
Units
Item
Units* (eg. mg)
text
C1519795 (UMLS CUI [1,1])
C0013227 (UMLS CUI [1,2])
Frequency
Item
Frequency* (e.g. BID)
text
C3476109 (UMLS CUI [1,1])
C0013227 (UMLS CUI [1,2])
Route
Item
Route* (e.g. PO)
text
C0013153 (UMLS CUI [1])
Reason for Medication
Item
Reason for Medication (e.g. Headache)
text
C0392360 (UMLS CUI [1,1])
C0013227 (UMLS CUI [1,2])
Start Date
Item
Start Date (e.g. 31 May 03)
date
C0013227 (UMLS CUI [1,1])
C0808070 (UMLS CUI [1,2])
Start time
Item
Start time (e.g. 14:10)
time
C0013227 (UMLS CUI [1,1])
C1301880 (UMLS CUI [1,2])
Taken Prior to Study
Item
Taken Prior to Study? (e.g. N)
boolean
C2826667 (UMLS CUI [1])
Stop Date
Item
Stop Date (e.g. 31 May 03)
date
C0013227 (UMLS CUI [1,1])
C0806020 (UMLS CUI [1,2])
Stop Time
Item
Stop Time (e.g. 23:00)
time
C0013227 (UMLS CUI [1,1])
C1522314 (UMLS CUI [1,2])
Ongoing Medication
Item
Ongoing Medication? (e.g. N)
boolean
C2826666 (UMLS CUI [1])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial